Compound: Crizotinib

Drug Target: MET, ALK, ROS1

Drug Target pathway: RTK signaling

Dataset


Associations from all tissue specific and pan-cancer ANOVA analyses overlaid. Hover the pointer over each circle to reveal the context-specific details of an association.

Retrieving drug sensitivity data...

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.